Abstract:Objective To examine the kinetics of plasma S100A12 and soluble receptor for advanced glycation end products (sRAGE) in infants and young children undergoing cardiopulmonary bypass ( CPB),and to investigate whether they could protective the occurrence of noninfectious pulmonary complication (NPC) after cardiac surgery.Methods This was a case-control study.The subjects included all children aged ＜3 years old who underwent cardiac surgery with CPB during the period from June 1st to July 31st 2011.The patient who showed pulmonary inflammation or had abnormal liver or renal function before surgery was excluded.The remain patients were divided into 2 groups according to whether they had developed NPC postoperatively.Twenty patients were grouped into NPC because they developed the complications of pleural effusion,chylothorax,partial lung collapse,pulmonary hypertensive crisis,airway disorders,pneumothorax,pneumomediastinum,or phrenic nerve palsy.Forty patients were categorized into the no-NPC group.Plasma concentrations of S100A12 and sRAGE were measured using ELISA at baseline,before CPB,immediately after CPB,1 h,12 h and 24 h after operation.Differences concentrations between two groups were analyzed with t test.A stepwise logistic regression analysis was used to indentify the independent risk factor for NPC.A P value ＜0.05 was considered statistically significant.Results Plasma levels of S100A12 and sRAGE dramatically increased immediately after CPB ( P ＜ 0.01 ).The levels of sRAGE dropped to lower than baseline level (P ＜0.05),while S100A12 was still at high level 24h after operation (P ＜0.01 ).Levels of S100A12 and sRAGE immediately after CPB in NPC group were significantly higher than the no-NPC group (P ＜ 0.05).Twenty-four hours after operation,levels of S100A12 were still higher in NPC group than no-NPC (P ＜ 0.01 ),while levels of sRAGE were similar in the two groups ( P ＞ 0.05 ).In the stepwise logistic regression analysis,plasma S100A12 level immediately after CPB remained as a independently predictor for postoperative NPC (OR =1.042,95％ CI:1.010 ～ 1.076,P =0.011 ).Levels of S100A12 immediately after CPB were positively associated with mechanical ventilation time ( r =0.47,P ＜ 0.01 ),duration of surgical Intensive Care Unit ( r =0.407,P =0.002) and hospital stay ( r =0.421,P =0.01 ).Conclusions Plasma levels of S100A12 and sRAGE were significantly increased immediately after CPB and the elevated plasma S100A12 immediately after CPB served as an early reliable biomarker of the occurrence and the prognosis of NPC after CPB in infants and young children.

Association of plasma mtDNA level with cardiopulmonary bypass-related inflammation in ICU patients

Effects of Cardiopulmonary Bypass on Plasma Levels of Procalcitonin and Cytokines

Detection of Intercellular Adhesion Molecule-1 during Pediatric Cardiopulmonary Bypass

Prospective Reassessment of the Association Between Pro-Inflammatory Factors and Prognosis after On-Pump Cardiac Surgery.

The Effects of Plasma from Cardiopulmonary Bypass on Store-Operated Ca2+ Channels Currents in Human Umbilical Vein Endothelial Cell in Vitro

Dynamic changes in HMGB1 levels correlate with inflammatory responses during cardiopulmonary bypass

The Clinical Value of Dynamic Determination of Serum Cardiac Troponin T,hypersensitive C-reactive Protein, Cytokine, Complement C3 and Complement C4 During Perioperation of Cardiopulmonary Bypass Surgery

Studying the Association of Plasma S100a12 and Noninfectious Pulmonary Complication in Infants and Young Children Following Cardiopulmonary Bypass

Studying the association of plasma S100A12 and noninfectious pulmonary complication in infants and young children following cardiopulmonary bypass (HUM1P.305)

CLINICAL STUDY ON PERIOPERATIVE CHANGE OF MYOCARDIAL NF-κB NUCLEAR TRANSLOCATION IN CARDIOPULMONARY BYPASS

Plasma mitochondrial DNA levels are associated with acute lung injury and mortality in septic patients

The effect of matrix metalloproteinase-9 in the inflammatory response to cardiopulmonary bypass

The Clinical Value of Dynamic Determination of Serum Cardiac troponin T and Hypersensitive C-reactive Protein Response to Cardiopulmonary Bypass

Levels of Plasma Apelin-36,Nitric Oxide and Tumor Necrosis Factor-alpha During Cardiopulmonary Bypass in Patients with Cardiac Procedures

Plasma Micrornas Reflecting Cardiac and Inflammatory Injury in Coronary Artery Bypass Grafting Surgery.

[Effect of Cardiopulmonary Bypass on CD11/CD18 Expression of Neutrophils in Children Undergoing Cardiac Surgery].

Elevated Levels of Plasma Mitochondrial DNA Are Associated with Clinical Outcome in Intra-Abdominal Infections Caused by Severe Trauma.

Dialysate cell-free mitochondrial DNA fragments as a marker of intraperitoneal inflammation and peritoneal solute transport rate in peritoneal dialysis.

Changes in levels of plasma mitochondrial DNA in patients with acute myocardial infarction and its clinical significance

Study on the Relationship of APACHE III and Levels of Cytokines in Patients with Systemic Inflammatory Response Syndrome after Coronary Artery Bypass Grafting

A prospective cohort study of dynamic cell-free DNA elevation during cardiac surgery with cardiopulmonary bypass